“Norton Healthcare is proud to be the first health care provider in Kentucky to offer this important new advance that can help increase screening for colon cancer,” said Thomas M. Woodcock, MD, an oncology specialist with Norton Cancer Institute, according to the report.
More articles on gastroenterology:
FDA approves generic version of GERD treatment drug
Gilead Sciences to allow drug makers to make generic version of HCV treatment Sovaldi
US Endoscopy releases new Roth Net polyp retriever
